BRIEF-Galena Biopharma confirms regulatory pathway for GALE-401

* Galena Biopharma confirms regulatory pathway for GALE-401 (anagrelide controlled release)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.